The largest-ever study on the effects of magnetic resonance imaging on pacemakers and defilibrators has concluded that the imagers are indeed safe for those with these cardiac rhythm management devices.
The largest-ever study on the effects of magnetic resonance imaging on pacemakers and defibrillators has concluded that the imagers are indeed safe for those with these cardiac rhythm management devices.
That’s the conclusion of a new study published in the October edition of Annals of Internal Medicine. The journal also published an editorial and a summary for patients on the findings.
Millions of Americans live with pacemakers and defibrillators, with hundreds of thousands implanted annually. Because of concerns about MRI machines’ intense magnetic fields causing the devices to malfunction, physicians have avoided MRI scans for such patients, though an estimated 75 percent of such patients could benefit from scans, the authors estimated.
A team led by Saman Nazarian, MD, of Johns Hopkins University, conducted 555 MRI scans on 438 patients with pacemakers (237) or defibrillators (201). Of the 555 MRI examinations, 222 (40 percent) were of the brain, 122 (22 percent) were of the spine, 89 (16 percent) were of the heart, 72 (13 percent) were of the abdomen or pelvis, and 50 (9 percent) were of an extremity. The team monitored patients before, during, and after the scans.
Overall, just three patients experienced problems with the devices, and none had a serious problem.
Patients were selected and treated based on previous safety studies. Therefore, only those with pacemakers manufactured after 1998 and defibrillators manufactured after 2000 were enrolled, and the researchers carefully followed programming and monitoring protocol.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa
March 6th 2025In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).